CRP and rheumatoid arthritis: A previous study found that 64 of 81 RA patients with serum zinc levels < 70 μg/dL who took polaprezinc (a zinc preparation) for 6 months or more exhibited significant increases in serum zinc concentrations and significant improvements in CRP and DAS28 [18].